What's on

  • February 22, 2018

    Virtual reality improves empathy in abusers

    Researchers from IDIBAPS and the University of Barcelona have developed a virtual reality system so that men who have committed a crime of gender violence can put themselves in the role of the victim. In the study, publiched in Scientific Reports, the authors show that men who commit domestic violence have a deficit in emotion recognition and that the virtual experience can improve their recognition of emotions. 

    Read the rest of this entry

  • January 24, 2018

    Fourth call of the PhD4MD biomedical research training programme for medical doctors

    The Centre for Genomic Regulation (CRG), the August Pi i Sunyer Biomedical Research Institute  (IDIBAPS), the Institute for Research in Biomedicine (IRB Barcelona), and the Vall d’Hebron Research Institute (VHIR) have launched the fourth call of the training programme “PhD for Medical Doctors – PhD4MD”.

    Read the rest of this entry

  • January 23, 2018

    Researchers identify a protein that keeps metastatic breast cancer cells dormant

    The time needed for breast cancer metastases (secondary lesions caused by cells that have escaped from the original tumour) to develop varies between patients, and little is known about the mechanisms that govern latency (the dormant state of cells that have already spread through the body). A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light on the molecular basis underlying how the expression of certain genes facilitates the spread of metastatic lesions. Dr. Aleix Prat, Head of the Clinical Oncology Department at Hospital Clínic and of the Translational genomics and targeted therapeutics in solid tumors research team at IDIBAPS, has participated in this study.

    Read the rest of this entry

  • December 16, 2017

    A new combination of antibiotics allows treating 60% of hospital-acquired pneumonia

    A study published in the journal The Lancet Infectious Diseases shows the ability of a new antibiotic (ceftazimida-avibactam) to treat hospital-acquired pneumonia, including ventilation-associated pneumonia. It has similar efficacy to one of the most used type of antibiotics in the treatment of this infection, carbapenems, but has the advantage of overcoming problems derived from its administration, such as the resistance of certain bacteria. Dr. Antoni Torres, Head of the Respiratory Intensive Surveillance Unit (UVIR) of the Hospital Clínic and head of the IDIBAPS team on Applied research in infectious respiratory diseases, critically ill patients and lung cancer, is the principal investigator of the study and first author of the article.

    Read the rest of this entry

  • December 11, 2017

    Moderate exercise training improves some of the Marfan syndrome symptoms in mice

    Regular physical activity is a common therapy for people with cardiovascular problems, but not recommended to those with Marfan syndrome, a rare disease of the connective tissue, but mainly affecting the cardiovascular system. A study conducted jointly by the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) has analysed for the first time this medical recommendation analysing the impact of exercise in the development of the disease in mice. The results, published in the scientific journal Journal of the American Heart Association, show that moderate exercise reduces the progression of the aortic aneurysm, one of the most severe symptoms of the disease which can cause arteries to break.

    Read the rest of this entry